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. In the 1970s, Dr Balfour Mount coined the term 'palliative care' to label his hospital-based service 2 . Since the late 1980s, the term 'supportive care' has been used to describe a variety of patient-care services that offer essentially every care intervention other than diseasedirected therapies, across settings ranging from survivorship to bereavement 3 . Nowadays, the term 'hospice care' is mostly used to describe community-based palliative care for patients in the last months of life. Considerable overlaps in the aims of and approaches to 'supportive care' , 'palliative care' , and 'hospice care' have been recognized (FIG. 1) , and we previously identified the similarities and differences between the definitions of these terms through a systematic review of the literature 4 . In 2013-2014, the World Health Organization (WHO) and Worldwide Hospice Palliative Care Alliance (WHPCA) published a report that categor ized the global level of palliative-care development according to the follow ing classification: no known hospice palliative-care activity (level 1), capacity-building activity (level 2), isolated palliative-care provision (level 3a), generalized palliative-care provision (level 3b), preliminary integration into mainstream service provision (level 4a), to advanced integration into mainstream service provision (level 4b) 5 . ' Advanced integration' was defined on the basis of the availability of a critical mass of palliative-care activism, comprehensive provision of all types of palliative care, broad awareness of palliative care, unrestricted access to opioids, the effect of palliative care on public health policy, development of education centres, academic links with universities, and the existence of a national palliative-care associ ation 5 . On the basis of the WHO-WHPCA classification, the nations that have achieved advanced integration of palliative care into their health-care systems were mostly developed countries located in North America, Western Europe, Australia, and Asia (specifically, Japan) 5 . The European Association for Palliative Care (EAPC) and the International Association for Hospice and Palliative Care (IAHPC) have also published an atlas of palliative-care development in Europe and Latin America, respectively 6, 7 . Even in countries recognized to have 'advanced integration' , however, substantial regional variation in palliative-care provision has been reported. For example, a survey of cancer centres in the USA showed that inpatient consultation teams, outpatient palliative-care clinics, acute palliative-care units, and institution-run hospices were present in 92%, 59%, 26%, and 31% of National Cancer Institute (NCI)-designated cancer centres, and 56%, 22%, 20%, and 42% of non-NCI-designated cancer centres, respectively 8 . Furthermore, fewer than half of the cancer centres were found to have palliative-care-fellowship training and research programmes in place.
Over the past decade, a growing body of literature has emerged that supports the role of palliative care in improving patient and caregiver outcomes [9] [10] [11] . With this evidence comes a heightened interest among professional organizations globally in integrating palliative care and oncology; however, what exactly does integration entail and how can it be assessed? A systematic review, published in 2015 (REF. 12 ), has examined the studies reported to date, and summarized the 38 different aspects (indicators) of integration identified (FIG. 2) , which goes some way towards defining how integration can be assessed. The objective of this Review, therefore, is to address the question of what integration involves; specifically, we discuss the various strategies to integrate oncology and palliative care through optimization of clinical infrastructures, processes, education, and research.
Evidence to support integrated care Several randomized controlled trials (RCTs) have provided level I evidence that supports the early involvement of palliative care for patients with advanced-stage cancer. For example, Temel et al. 13, 14 published a landmark trial that enrolled 151 patients within 8 weeks of diagnosis of metastatic non-small-cell lung cancer (NSCLC) and randomly assigned them to receive routine oncological care either alone or combined with early specialist palliative care. The early provision of palliative care was associated with better quality of life (QoL), fewer depressive symptoms, less aggressive care at the end of life, improved longitudinal prognostic awareness, and longer survival (median 11.6 months versus 8.9 months; P = 0.02) 13, 14 . More recently, in a large cluster randomization trial that compared special ist palliative care to routine oncological follow up in 461 patients with metastatic solid tumours and a prognosis of 6-24 months, use of palliative care was associated with improved QoL, symptom burden, and patient satisfaction over time, whereas the group assigned to standard oncological care experienced a deterioration in these domains 15 . A trend favouring the palliative-care arm for the primary outcome of patient-reported QoL, as assessed by Functional Assessment of Chronic Illness Therapy -Spiritual Well-Being (FACIT-Sp) questionnaire, was observed at 3 months (mean change score 1.60 versus −2.00; P = 0.07), which became statistically significant at 4 months (mean change score +2.46 versus −3.95; P = 0.006) 15 . In contrast to involvement of an interdisciplinary palliative-care team in oncological care, as investigated in the aforementioned trials, Bakitas et al. 16 examined the effect of combining nurse-led palliative-care intervention and standard care in the Project ENABLE II trial. QoL and mood were found to be significantly better in the palliative-care arm of this trial (mean treatment effect of 4.6 for QoL (P = 0.02) and −1.8 for depressed mood (P = 0.02), although symptom burden, quality of end-of-life care and survival were similar 16 . In the subsequent ENABLE III trial 17 , the investigators examined early nurse-led palliative care, introduced within 30-60 days of a diagnosis of advanced-stage cancer, in comparison to delayed palliative care initiated 3 months later in a wait-list-design study. Unlike in the previous study, QoL, symptom burden, and mood in ENABLE III did not differ between the two groups at 3 months, 6 months or 12 months after enrolment 17 . Interpretation of these findings is complicated by the facts that half of the delayed-care group received a consultation by a palliative-care team ahead of the nursing intervention, and that only 207 of the 360 patients planned were enrolled in this study 17 . Despite the lack of benefit demonstrated by these outcomes, the 1-year survival
Key points
• Patient referral to specialist palliative care is associated with improved quality of life, symptom control, patient and caregiver satisfaction, illness understanding, end-of-life care, costs of care, and, potentially, survival • Oncologists and general practitioners have an important role in the delivery of primary palliative care, and in facilitating timely referral of patients to specialist palliative-care teams • The integration of oncological and palliative care needs to be tailored to the demands of the individual health-care system and hospital setting, according to the resources available locally • Outpatient palliative-care clinics are a hallmark of integration, providing patients with access to specialist palliative care early in the disease trajectory, and can accommodate multiple repeat visits over time • Routine symptom screening with automatic referral criteria, combined (multidisciplinary) patient-care rounds, renaming palliative care to 'supportive care', and embedded oncology-palliative-care clinics represent potential strategies to encourage integration of care • Education initiatives include a mandatory palliative-care rotation for oncology fellows, combined palliative care and oncology educational activities for trainees, and continuing medical education in palliative care for practicing oncologists Nature Reviews | Clinical Oncology
Supportive care
Palliative care
Hospice care
No evidence of disease . Supportive care is defined as "the provision of the necessary services for those living with or affected by cancer to meet their informational, emotional, spiritual, social or physical need during their diagnostic treatment or follow-up phases encompassing issues of health promotion and prevention, survivorship, palliation and bereavement." 120 Palliative care is supportive care for patients with advanced-stage disease, and includes interventional programmes used in both acute-care hospitals and the community 3, 4 . Hospice care is a form of community-based palliative care predominantly serving patients and their loved-ones at the end of life. Under this conceptual framework, hospice care is a branch of palliative care, and palliative care is, in turn, a branch of supportive care. Supportive care also includes many other services, such as teams that manage toxicities of cancer treatments and cancer-related complications (for example, dermatologists who treat rash associated with the use of EGFR-tyrosine-kinase inhibitors, and pulmonologists who perform bronchoscopy and airway stenting), wound-care teams, psychosocial oncology, social workers, and chaplains. Bereavement care refers to support provided to family caregivers after the death of the patient, which can last for months to a year or longer.
rate was improved in the early-palliative-care group (63% versus 48%; P = 0.04), although the difference in overall survival between the cohorts did not reach statistical significance (median survival 18.3 months versus 11.8 months, P = 0.18) 17 . The results of these clinical trials and those of a large number of prospective cohort and retrospective studies provide important insights into the potential benefits associated with the integration of palliative care into the oncological care of patients with advancedstage cancer 11, [18] [19] [20] [21] [22] [23] [24] , and raise some questions on how we can improve care. First, outpatient access to palliative care is clearly important; because oncological care is predominantly ambulatory in nature, outpatient pallia tive care facilitates early access and longitudinal monitoring throughout the disease trajectory.
Second, the interdisciplinary nature of palliative care enables the multidimensional care needs of patients to be addressed. The two nurse-led palliative-care RCTs had mixed findings 16, 17 , and two nonrandomized prospective studies designed to evaluate palliative care delivered by advanced-practice nurses also reported limited benefits of this approach 25, 26 . By contrast, the findings of studies incorporating interdisciplinary involvement were more consistent [13] [14] [15] . Of note, however, the heterogeneity in study designs precludes any direct comparisons between the interdisciplinary versus unidisciplinary approaches; RCTs of these interventions are needed before we can draw any definitive conclusions.
Third, when and who should be referred for early palliative care remains a topic of debate. In the four aforementioned RCTs, palliative-care referral was based on diagnosis and prognosis, instead of symptom burden. This method of referral is in contrast to that used in contemporary practice, in which most clinicians refer patients based on care needs. The timing of referral will be discussed further in a later section of this Review.
Fourth, a survival benefit has been associated with early palliative care for patients with advanced-stage cancer 17 . This finding was, however, a secondary outcome, and not consistently observed in all studies. Could palliative care improve survival by optimizing symptom control; enhancing the patient's eligibility for and tolerance of cancer treatments; maximizing psychosocial support; preventing premature death from overly aggressive cancer care; minimizing other aggressive interventions, such as intubation at the end of life; or a combination of these factors? Further studies are needed to address these questions.
Fifth, oncologists have an important role in delivering primary palliative care. Primary palliative care refers to the delivery of supportive care by health-care professionals who are not palliative-care specialists, such as oncologists and primary-care clinicians 27, 28 . By contrast, secondary palliative care involves palliative-care specialists acting as consultants, and in tertiary palliative care, palliative-care specialists assume responsibility as the attending team for patients with complex issues -for example, in the acute palliative-care unit. Oncologists attend to patients in the front lines of care and are, therefore, essential in providing proper symptom assessments and prompt treatments. Integration of oncology and palliative care necessitates collaboration and communication between primary, secondary, and tertiary palliative-care teams regarding their roles and responsibilities, such that the different teams can function in unison.
Sixth, the role of general practitioners (or primarycare providers) in the provision of primary palliative care remains undefined. All of the four RCT we discussed were conducted in North America, with no defined primary-care involvement. In many countries and continents, however, family physicians are extremely important to the delivery of palliative care. This subject is an area of further research 29 . Figure 2 | Indicators of successful integration of palliative care into oncology practice. Previously, we reviewed the literature to identify factors relevant to different aspects that are associated with efforts to integrate palliative care into clinical practice in oncology; we identified four indicators related to clinical structure, 13 indicators related to clinical processes, eight related to education, four related to research, and nine related to administration 12 . Subsequently, a Delphi study involving international experts in palliative care identified 13 major (>90% consensus) indicators and 30 minor (70-90% consensus) indicators of integration 82 . Major indicators were defined as the most-relevant and important indicators related to integration. Eight of the major indicators are highlighted with an asterisk and five represented new additions that were not identified in the systematic review and are not shown in this figure (that is, routine documentation of advance care plans for patients with advanced-stage cancer; proportion of outpatients with pain assessed on either of the last two visits before death; proportion of patients with two or more emergency-room visits in last 30 days of life; place of death consistent with patient's preference; combined educational activities for palliative care and oncology fellows/trainees). These indicators represent strategies to improve efforts to combine these disciplines of care. Furthermore, these indicators could potentially be used to assess the level of integration, which can in turn enable patients and clinicians to identify cancer centres that offer a high level of palliative-care access, policy makers and administrators to conduct programme evaluation and allocate appropriate resources to improve care, educators to develop curricula, and researchers to assess how integration can improve outcomes.
Finally, access to secondary and tertiary palliative care remains limited. Palliative-care referral was permissible in the usual-care arms of the aforementioned RCTs, but few patients in these cohorts were referred to receive specialist palliative care [14] [15] [16] [17] . A study has revealed that even in well-integrated oncologypalliative-care programmes, only approximately 50% of patients receive palliative care before death 30 . In multiple other studies, investigators have also demonstrated that palliative-care access is limited and often delayed 31, 32 . Numerous barriers to early palliative-care referral have been recognized, including oncologistrelated, patient-related, palliative-care-related, and system-related challenges 8, [33] [34] [35] .
Conceptual framework for cancer care
Examining the care needs of a typical patient with cancer is important to understanding how oncology and palliative-care teams can better integrate to improve patient outcomes. The key requirements include cancer manage ment, attending to the patients' personal care needs, and addressing comorbidities (FIG. 3a) . Traditionally, the oncology team, palliative-care team, and primary care and other subspecialties work in silos (that is, in isolation). Integration of oncology and palliative care involves communication, collaboration, and sharing of resources and expertise among these teams to more-comprehensively address the care needs of patients 36 .
Personal care needs can be subdivided into four categories: acute issues; chronic issues; psychosocial issues; and existential and/or spiritual issues (FIG. 3b) . This model provides some insights into the operation of the oncology-palliative-care interface. First, addressing the most-acute needs before dealing with the morechronic and time-consuming issues is important. For instance, focusing on managing the acute-pain crisis in a patient before discussing their financial distress and spirituality is a logical approach. Once their pain is under control and trust has been built, the patient will be more prepared to discuss deeper emotional issues. Second, onco logy and primary-care teams should provide as much supportive care as possible, and the palliative-care team can then build on their efforts to complete the spectrum of care. For instance, if a patient has already been treated for peripheral neuropathy, and chemotherapyinduced nausea and vomiting by the oncology team, the palliative care team can focus on addressing fatigue, early satiety, anxiety, and discussions regarding advance care planning. Third, interdisciplinary palliative care teams are needed to appropriately address the multi dimensional and complex psychosocial needs of patients and their care givers. Finally, a single visit cannot fully address all of the dynamic care needs of a patient; thus, longitudinal follow-up consultations are needed in order to fully support the patient and their family over time.
Oncology teams, psychosocial teams, and palliativecare teams often address the complex personal needs of patients with advanced-stage cancer to variable extents, owing to their focus on different aspects of care (FIG. 4) .
Oncologists have a critical role in providing supportive care in the front lines; however, expecting these professionals to fully address all the patient's personal care needs is unrealistic because of time constraints, limited experience with or access to psychosocial resources, variable interest in this aspect of care, and the need for special ized training. Indeed, patients have been reported to prefer their oncologists to be optimistic about treatment options and to avoid pessimistic discussions about end-of-life care 37 , suggesting the focus of oncologists on cancer treatment and physiological symptom relief, rather than psychosocial or existential issues, might be desired. Consistent with this observation, several studies have shown that patients with cancer often prefer to discuss advance care planning with a physician who they have never met, rather than their own clinical oncologist 38, 39 . The type of health professional that is best suited to engage patients and families in end-of-life discussions remains to be defined and needs to be tailored to the needs of each individual. Psychosocial teams consist of professionals from different disciplines (for example, psychiatrists, psychologists, child-life counsellors, social workers, and chaplains), each with a unique focus for care. Because of the narrow focus of each discipline, patients who are exposed to only one psychosocial service might not have all their emotional, social, and spiritual needs addressed adequately. By contrast, patients with access to multiple psychosocial services might encounter some redundancy in their care. Palliative-care teams, because of their interdisciplinary nature and communication among team members, can address the patients' personal needs efficiently and comprehensively.
Structures to support integrated care Outpatient clinics, inpatient consultation teams, palliative-care units, and home-based palliative-care services are all important branches of palliative care, each focusing on delivering care to patients at different stages of the disease trajectory, and in different settings (TABLE 1) . As mentioned earlier, outpatient clinics are a hallmark of oncology-palliative-care integration because they provide patients with access to specialist palliative-care early in the disease course and can accommodate large numbers of patient visits over time.
Currently, these palliative-care clinics are available in less than half of all palliative-care programmes 40, 41 . Only a few groups, predominantly located in North America and Europe, have published their experience related to the processes and outcomes of such programmes [42] [43] [44] [45] [46] [47] [48] . In a study published in 2013 49 , investigators documented the practice of 20 palliative-care clinics in the USA, and identified wide variations in the availability, staffing, and patient volume of each clinic. These clinics provide patients with early pain and symptom management to prevent crisis 50 , longitudinal psychosocial care to improve their wellbeing, repeated discussions to enhance their understanding of the disease 51 , and advance care planning to minimize aggressive end-of-life care 22 . Importantly, a single visit to even a specialist palliative-care unit has been shown to be inadequate to address the complex symptom burden in patients with advanced-stage cancer 52, 53 . In a cohort study, investigators found that patients who were first referred to palliative care as outpatients had improved outcomes at the end of life, compared with those first referred as inpatients to the same interdisciplinary palliative-care team, such as a lower rate of in-hospital death (18% versus 34%; P = 0.001), and lower rates of intensive-care-unit admission (4% versus 14%; P = 0.001), prolonged hospitalization for ≥2 weeks (8% versus 20%; P = 0.002), and emergency-room visits (48% versus 68%; P <0.001) in the last 30 days of life 18 . Furthermore, outpatient referrals occurred significantly earlier than inpatient referrals (median duration between referral and death of 3.7 months versus 0.7 months, P <0.001), which allowed for more visits to palliative-care units and greater opportunities for timely interventions 18 . Figure 4 | Management of personal care needs. The diagrams depict schematically how different health-care teams can address the personal needs of patients with cancer, including the acute issues, chronic issues, psychosocial issues, and existential issues. Oncology teams have an important role in providing primary palliative care; however, addressing all personal care needs comprehensively might be difficult for these teams, owing to time constraints, a lack of routine screening for care needs, unavailability of interdisciplinary team members, and limited advanced expertise in supportive-care issues. Psychosocial teams often have a narrow focus for palliative care (for example, spirituality for chaplains, anxiety and depression for psychologists and psychiatrists, family and financial issues for social workers, child care for child-life specialists), and rarely address physical symptoms fully. Palliative-care teams, because of their interdisciplinary nature and expertise, can comprehensively manage the personal care needs of patients, longitudinally.
Processes to support integrated care
Embedded versus standalone clinics Embedding a palliative-care consultant or team geographically within the oncology clinic has the potential advantages of improving the volume and timeliness of referral and reinforcing communication between the oncology and palliative-care teams, while also maximizing convenience for patients. At the same time, the embedded approach mandates allotment of clinical space and adequate resources to a fully functional palliative-care team within the oncology clinic. In large cancer centres, in which each oncology clinic is organized by treatment modality and tumour site (for example, thora cic medical oncology or breast radiation oncology), the palliative-care service might be at risk of fragmentation, because comprehensive palliative care necessitates a sophisticated interdisciplinary team and adequate clinic space that are only available in standalone clinics, where resources can be pooled. Furthermore, the principles and practice of palliative care, involving symptom manage ment and psychosocial care, are common regardless of disease site; thus, tumour-site-specific approaches to palliative care might be unwarranted 54 . In smaller general oncology clinics, the embedded clinic model of palliative care might not be cost-effective owing to the low number of referrals. Only a limited number of studies have reported on the practices and related outcomes of embedded clinics 55, 56 ; therefore, current evidence is insufficient to determine if they are superior to nonembedded clinics with regard to palliative-care access, patient outcomes, and costs. Further research is needed to examine the true value of embedded clinics in various oncology settings.
Physician-driven versus automatic referral
The questions of who, when, and how to refer patients to palliative care are complex, and the answers might depend on national and/or regional health-care policies, local resources, comprehensiveness of the palliative-care teams, patient characteristics, and the level of palliative care provided by oncology and/or primary-care teams. Currently, the two main approaches to specialist palliative-care referral are oncologist-driven referral, and automatic referral (FIG. 5) .
At present, oncologist-driven referral of patients with advanced-stage cancer to palliative-care services is the norm, worldwide. This approach requires oncologists to identify patients who have specific symptoms and supportive-care needs, and to initiate a referral. Access to palliative care is currently inequitable, owing to variable detection of such patients and differential thresholds for referral 33, 57 , and involvement of specialists in palliative care is often delayed (TABLE 2, FIG. 5) . Routine symptom screening in the oncology setting has the potential to increase awareness of supportive-care needs and enhance patient referral to specialist palliative care, although this remains to be confirmed 58, 59 . The second approach, automatic referral, involves the use of predefined criteria relating to the patients' diagnoses, prognoses, and/or needs to routinely trigger a palliative-care consultation. Automatic referral can be used in conjunction with or instead of physician-driven referral. The four RCTs discussed earlier all used diagnosis-based and/or prognosis-based criteria to trigger a palliative-care referral [14] [15] [16] [17] . Indeed, of the potential approaches to patient referral, this approach offers the greatest extent of palliative-care access and has the highest level of supportive evidence. This referral paradigm remains, however, more a vision than a reality, as no hospital has a large enough palliative-care team with adequate infrastructure and resources to provide care to most patients with cancer.
Automatic referral applying more-selective criteria, based on a combination of time from diagnosis, patient prognosis, and personal care needs, might help to streamline referral practices. Importantly, these criteria need to be dynamic in order to tailor the patient volume to the available resources of the palliative-care team. In the clinical setting, institution of care pathways for palliative-care referral requires a consensus on appropriate institution-specific criteria, a process to routinely screen for patients who meet these criteria, a commitment to ensure adequate resources to support a sustainable programme that can provide timely longitudinal care, and the implementation of systems to provide improvements in quality. Carlson et al. 60 conducted a RCT to compare three types of distress screening: minimal screening, full screening, and full screening coupled with the option for patient referral to the psychosocial team (the 'triage' group). The primary end point of this trial, distress at 3 months, did not reach statistical significance; however, the triage group had improved distress scores and a greater number of referrals to the psychosocial team at follow up, compared with the minimal screening group 60, 61 . Referral to the psychosocial team was in turn associated with greater reductions in anxiety and depression 60, 61 . Findings of this study highlight the need to link screening with referral.
Several investigators have proposed automatic triggers for palliative-care referral (or clinical-care pathways) 62, 63 . Weissman et al. 64 from the Center to Advance Palliative Care, a national member-based organization aimed at improving palliative care throughout the USA 65 , proposed a consensus list of criteria for palliative-care assessment at the time of patient admission. Subsequently, researchers at the Mount Sinai Hospital, New York, NY, USA, conducted a pilot qualityimprovement study to examine the implementation of a set of standardized criteria, which partially overlapped with the CAPC criteria, for patient referral to inpatient palliative-care consultation over a 3-month period 66 .
Specifically, patients were automatically referred to a palliative-care team if they met any of the following criteria: stage IV cancer; stage III lung or pancreatic cancer; prior hospitalization within 30 days (excluding routine chemotherapy); hospitalization for longer than 7 days; or uncontrolled symptoms, including pain, nausea, vomiting, dyspnoea, delirium, and psychosocial distress 66 . In a before-after comparison, a significant increase in the frequency of palliative-care referral (82% versus 41%; P <0.0001), a reduction in the 30-day readmission rate (17% versus 36%; P = 0.02), and a nonsignificant increase in the hospice-utilization rate (25% versus 14%; P = 0.15) were reported for patients who met these criteria 66 . The National Comprehensive Cancer Network (NCCN) has also proposed a list of consensus criteria for screening of patients care needs and subsequent referral of patients to receive palliative care 67 . In a retrospective cohort study of patients admitted to the Gastrointestinal Oncology Service (GIOS) at the Memorial Sloan Kettering Cancer Center, New York, NY, USA, Glare et al. 68 examined the use of six NCCN criteria to screen for palliative care needs and stratify patients for a palliative-care referral; automatic triggering of referral was based on the presence of any one of the six NCCN screening criteria. Patients in the automatic-trigger group underwent a greater number of consultations (47 among 113 patients versus 15 among 124 patients in the control group, for whom referral was not auto matically triggered; P <0.0001) 68 . Among the patients who underwent consultations, those from the automatic-trigger group had a lower average baseline symptom score (1.6 versus 2.4; P = 0.005) 68 . The timing of consultation was also earlier in the automatic-trigger group (15 months versus 22 months after diagnosis), although this difference was not statistically significant 68 . Glare et al. 69 also developed an abbreviated screening tool for identifying patients with unmet palliative-care needs who would benefit from an outpatient consultation. The criteria for referral to an outpatient consultation include: the presence of metastatic or locally advanced cancer; decreased Eastern Cooperative Oncology Group (ECOG) performance status; the presence of one or more serious complications of advanced-stage cancer that are associated with a prognosis of less than 12 months; the presence of one or more serious comorbid diseases that are also associated with poor prognosis; and the presence of palliative-care problems, such as uncontrolled symptoms 69 . Using the final criteria list, the patient is assigned a score on a scale from 0 to 13, with a higher score indicating a greater palliative-care need. A score of 4 points was found to have the best sensitivity and specificity for identify ing the patients who met a 'broad' definition of the need for palliative care (metastatic or locally advanced cancer, a limited prognosis, or an active source of suffer ing) 69 . This tool was subsequently revised to include prolonged length of stay as an extra item (taking the total to 11 items and adding an extra point to the range of possible scores), and examined for its content, construct, and criteria validity 70 . A cutoff of 5 points out of 14 points was chosen as the optimal threshold for triggering referral to an inpatient palliative-care consultation, with a positive predictive value of 80% and negative predictive value of 44% using the NCCN referral criteria as a standard 70 . Further research is needed to examine the optimal criteria for outpatient palliative-care referral tailored to the local health-care system and resource availability.
'Supportive care' versus 'palliative care'
Palliative care is, by definition, supportive care that focuses on patients with advanced-stage diseases (FIG. 1) 3,4 . Oncologists are the gatekeepers of palliativecare referral and, therefore, the prevailing misconception that 'palliative care' is associated with death and dying can be a barrier to palliative-care access 71 . A survey revealed that the term 'palliative care' is more likely to be perceived as a barrier to referral by medical oncologists and mid-level health-care providers, decreases hope and causes distress in patients and families, and is interpreted as being synonymous with hospice care, compared with the term 'supportive care' 72 . As a result of these findings, the palliative-care programme at our institution changed its name to 'supportive care' . In a before-after comparison, our group found that the number of referrals significantly increased (by 41%; P <0.001) and outpatients were referred earlier (median time from hospital registration to palliative-care consultation of 9.2 months versus 13.2 months; P <0.001) after this name change 73 . A repeat survey found that both haematological and solid tumour specialists 
Level of evidence
Control arms of RCTs [14] [15] [16] [17] Retrospective and prospective cohort studies 18, 121 Intervention arms of RCTs [14] [15] [16] [17] Retrospective and prospective case series 64, [66] [67] [68] RCT, randomized controlled trial.
were markedly more receptive to the term 'supportive care' when considering early referral 74 . In a survey of Canadian oncology-society members, the investigators reported that approximately one-third of onco logists indicated that they would be more likely to refer patients earlier if 'palliative care' was renamed 'supportive care' 75 . In addition, Maciasz et al. 76 found that patients perceived the term 'supportive care' more favourably than 'palliative care' . Certain aspects of supportive care, such as management of neutropenic risk, are predominantly under the direction of oncologists; however, many domains, such as management of fatigue and peripheral neuro pathy, require close communication and collaboration between the oncology and palliative-care teams to deliver optimal supportive care 77 .
Combined patient-care rounds
Combined tumour boards represent another opportunity to integrate palliative care and oncology, through enhanced communication. Traditionally, multidisciplinary tumour boards bring together medical, radiation, and surgical oncologists, as well as pathologists and radiologists, to discuss cancer treatment, with the aim of improving decision-making. Inclusion of a member of the palliative-care team in these meetings could potentially broaden the patient-care discussion, trigger palliative-care consultations, and open more options for disease management 78 . Alternatively, routine involvement of oncologists in palliative-care-team meetings might also strengthen this partnership to enhance care 79, 80 . Combined tumour boards require a concerted effort from both oncology and palliative-care teams, however, and in larger centres with multiple tumour boards, it might not be possible to include a palliative-care specialist in all discussions.
Education to support integration
Education is one of the most important routes to enhancing integration of oncological and palliative care 81 . Through an international Delphi survey completed in 2015 82 , four major indicators of oncologypalliative-care integration related to education were identified: a didactic palliative-care curriculum for oncology fellows, provided by palliative-care teams; continuing medical education in palliative care for attending oncologists; combined palliative care and oncology educational activities for fellows and trainees; and a routine rotation in palliative care for oncology fellows.
Continuing medical education for oncologists
Similar to the scenario in other branches of oncology, the practice of supportive and/or palliative care is rapidly evolving, with new developments in symptom-management strategies, novel communication techniques, and shifting paradigms on palliative-care referral and topics related to end-of-life care. Survey studies have revealed that a vast majority of oncologists felt that they should be providing palliative care and that they should have a high level of proficiency in palliative care, but they had mixed opinions about their own training in this area 83, 84 . Recognizing this knowledge gap, several organizations have developed continuing education curriculums for oncology professionals. We discuss some examples in the following paragraphs.
The Education in Palliative and End-of-life Care for Oncology (EPEC-Oncology ® ) project is a programme focused on oncologists, with educational information delivered online, via CD, or on paper 85 . This educational programme has 15 modules (comprehensive assessment; cancer-related pain management; symptoms; loss, grief and bereavement; survivorship; last hours of living; communicating effectively; clarifying diagnosis and prognosis; negotiating goals of care; clinical trials; withdrawing nutrition and/or hydration; conflict resolution; advance care planning; physician-assisted suicide; cancer doctors and burnout), and three plenary sessions (gaps in oncology, models of comprehensive care, and charting the future) 85 . Its 'train-the-trainer' courseswhereby a small number of individuals receive formal training in the relevant topic, as well as how to teach others the information they learn -facilitate wide dissemination of the curriculum, with at least one of the modules reaching approximately 120,000 professionals in 2 years via only 184 'Certified EPEC ® Trainers' 86 . A process evaluation of the programme among 195 participants suggested that the EPEC ® modules were clinically relevant and that the material presented was clear and easy to understand, and most participants felt that their practice behaviour would probably change as a result of having attended the course 87, 88 . The End-of-Life-Nursing Education Curriculum (ELNEC) programme was developed by nurses, for nurses, and is administered by the American Association of Colleges of Nursing (AACN) 89 . This curriculum consists of eight modules: nursing care at the end of life; pain management; symptom management; ethical and legal issues; cultural considerations in end-of-life care; communication; loss, grief, and bereavement; and preparation for and care at the time of death 83, 84 . An oncologyspecific programme is also available. Similar to EPEC, train-the-trainer courses are available 90, 91 . The ELNEC curriculum has been translated and implemented in more than 70 countries, with approximately 20,000 nurses and other health-care professionals participating in the courses 89 . The Palliative care Emphasis programme on symptom management and Assessment for Continuous medi cal Education (PEACE) is a Japanese programme in which nine training modules are delivered in-person over 2 days 92 . Over 37,000 physicians have completed the programme 93 . In a before-after comparison, investigators noted statistically significant improvements in palliative-care knowledge (measured using the palliative-care knowledge questionnaire for PEACE (PEACE-Q) at baseline, then immediately after training, and again 2 months later; P <0.0001) and self-reported competencies in palliative-care delivery (according to the Palliative Care self-reported Practice Scale (PCPS) and the Palliative Care Difficulties Scale (PCDS); P <0.0001 by both measures) among 85 physicians who participated in the programme 94 .
Other educational curricula in palliative care include the Pallium Canada's Learning Essential Approaches to Palliative and End-of-Life Care (LEAP) 95 [104] [105] [106] [107] . Further research is needed to assess the effectiveness of these programmes and their effect on patient and caregiver outcomes.
Palliative-care rotation for oncology fellows
The second edition of the Global Core Curriculum in Medical Oncology, which was published in 2010, is endorsed by both ASCO and ESMO, and outlines specific competencies for oncologists related to supportive and palliative care (BOX 1) 108, 109 . In the aforementioned Delphi survey 82 , international experts reached a consensus that oncologists should ideally undertake a palliative-care rotation of at least 1 month in duration. Currently, approximately 25% of oncology fellows in the USA participate in a palliative-care rotation 8, 110 . A clinical rotation is essential for integration of these disciplines because it could help oncology fellows to acquire knowledge of the basic principles of symptom management and communication, understand when referral is appropriate, and build a working relationship with the palliative-care team. A rotation could also help to de-stigmatize palliative care, and might result in increased interest among oncologists for subspecialization in palliative oncology.
Key challenges to address include standardizing the educational elements of the palliative-care rotation, ensuring that the members of the interdisciplinary palliative-care team have adequate time for teaching, and defining the optimal timeframe for the rotation. Furthermore, commitment from National Accrediting Agencies is needed to mandate palliative-care rotations for oncology fellows. In addition, the relationship between such training and palliative-care referral needs to be defined: on the one hand, increased familiarity with the palliative-care service might promote referral; on the other hand, oncologists who are highly confident with the delivery of palliative care might be less likely to refer patients to units that specialize in this discipline 33 . Further studies are required to examine this possible paradox.
Oncology training for palliative-care fellows
Integration of oncology and palliative care is a two-way street. Similar to the way in which patient care might be improved by educating oncologists in palliative care, a rotation in medical and/or radiation oncology for palliative-care fellows, to increase their familiarity with the natural history of cancer, cancer-treatment modalities, and the complex decision-making process surrounding cancer treatment at the end of life, could be of benefit. Such rotations might also help palliative-care specialists and oncologists nurture a mutual understanding, to strengthen their partnerships. In the USA, palliative-care fellowships last only 1 year, which makes inclusion of a mandatory oncology rotation challenging.
Accreditation of palliative care
Accreditation is crucial for the sustainability of palliative care as a profession because it enables patients to be reassured of the standard of care they receive, prospective trainees to be attracted to this new discipline, practicing clinicians to be recognized for their expertise, educators to standardize the fellowship programmes, researchers to evaluate programme outcomes, and administrators and policy-makers to allocate resources 111 . Palliative medicine achieved specialty/subspecialty status in the UK in 1987 and in the USA in 2006, and will be awarded this status in Canada in 2016 (REFS 112, 113) . This discipline has also been established as a specialty in multiple countries in the Asia-Pacific region, including Australia, New Zealand, Hong Kong, Japan, Taiwan, Malaysia, Singapore, and India 114 . Many other countries in Europe, Asia, the Middle East, South America, and Africa are actively working toward accreditation of palliative care.
Dually trained palliative oncologists 'Palliative oncologists' , who are dually trained in both palliative care and oncology, can further foster communication, collaboration, and 'cross-pollination' between the two teams to further catalyse the process of integration 115 . Of note, individuals boarded in palliative care might be attractive candidates for oncology training programmes because of their unique specialist experience in an important aspect of oncology. In addition to clinical work in both specialties, palliative oncologists can take an active role in educating oncologists about palliative care, teaching palliative-care teams about oncology, conducting palliative-oncology research, and advocating for increased allocation of resources and greater awareness. For these reasons, many larger comprehensive cancer centres in the USA now include at least one palliative oncologist.
Research to support integration
In the era of evidence-based medicine, results of wellconducted studies designed to support palliative care can have an important effect on clinical practice. For instance, the RCT in which Temel and co-workers 14 evaluated early integration of palliative care in oncology captured the attention of oncologists and palliative-care specialists worldwide, and contributed to a shifting paradigm of care; since this trial was published in 2010, the number of publications related to such integration has grown dramatically 12 .
Despite the expansion in palliative-care research, much room for improvement remains. A sample of the palliative-oncology literature revealed concerns regarding both the quantity and quality of studies 116 . For instance, 51% of original articles in palliative oncology were found to be case reports or case series 116 . RCTs comprised 6% of the studies identified, and the methodological scores for these trials were generally low 117 . Approximately 97% of the palliative-care literature is derived from developed countries, with North American and Europe contributing 41% and 39%, respectively 116 . Inadequate funding and a lack of trained researchers are two major barriers to palliative-care research 118, 119 . To further promote integration of oncology and palliative care, researchers need to conduct adequately powered, well-designed clinical studies that address fundamental questions related to integration. Such studies could examine the effects of palliative-care interventions on clinically meaningful outcomes, such as symptom management, psychosocial and spiritual care, patient-clinician communication, and decision-making needs at different stages of the disease trajectory (for example, at diagnosis, during cancer treatments, and in last months and days of life). Collaboration with oncologists would be helpful to ensure the research questions are relevant to their practice.
Conclusions
In only half a century, palliative care has evolved from a philosophy of care to a professional discipline of medicine in many countries, with a defined body of supporting knowledge. The question is no longer whether palliative care should be provided to patients with cancer, but when and how it should be delivered to optimize patient outcomes. As highlighted in this Review, concerted efforts to grow the clinical infrastructure, optimize the clinical processes, standardize the education curricula, and conduct ground-breaking research are needed to promote integration of oncological and palliative care.
Exactly how integration should occur needs to be tailored to the characteristics of the health-care system, to the hospital setting, and to the local resource availability. A Delphi study of international experts identified 13 major and 30 minor indicators of integration of specialty palliative care and oncology programmes in hospitals with ≥100 beds (FIG. 2) 82 , which might be used to identify centres with a high level of integration, and facilitate benchmarking, quality improvement and research. The model for integration of palliative care and oncology in small community hospitals might differ dramatically compared with large academic cancer-treatment centres. Furthermore, the interface between primary and secondary and/or tertiary palliative care remains to be defined. Oncologists, palliative-care specialists, educators, researchers, hospital administrators, funding bodies, accreditation agencies, pro fessional organizations, and governments all have a role in this important movement to optimize patient care.
